JP2024539630A5 - - Google Patents
Info
- Publication number
- JP2024539630A5 JP2024539630A5 JP2024522219A JP2024522219A JP2024539630A5 JP 2024539630 A5 JP2024539630 A5 JP 2024539630A5 JP 2024522219 A JP2024522219 A JP 2024522219A JP 2024522219 A JP2024522219 A JP 2024522219A JP 2024539630 A5 JP2024539630 A5 JP 2024539630A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- sequence described
- polynucleotide according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163262602P | 2021-10-15 | 2021-10-15 | |
| US63/262,602 | 2021-10-15 | ||
| PCT/IB2022/059885 WO2023062604A1 (en) | 2021-10-15 | 2022-10-14 | Anti-steap2 chimeric antigen receptors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539630A JP2024539630A (ja) | 2024-10-29 |
| JP2024539630A5 true JP2024539630A5 (https=) | 2025-10-21 |
Family
ID=85988436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522219A Pending JP2024539630A (ja) | 2021-10-15 | 2022-10-14 | 抗ｓｔｅａｐ２キメラ抗原受容体及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230192803A1 (https=) |
| EP (1) | EP4415727A4 (https=) |
| JP (1) | JP2024539630A (https=) |
| KR (1) | KR20240099281A (https=) |
| CN (1) | CN118103050A (https=) |
| AU (1) | AU2022362872A1 (https=) |
| CA (1) | CA3234494A1 (https=) |
| IL (1) | IL312003A (https=) |
| MX (1) | MX2024004620A (https=) |
| TW (1) | TW202342507A (https=) |
| WO (1) | WO2023062604A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250172654A (ko) * | 2023-04-11 | 2025-12-09 | 메디뮨 엘엘씨 | Steap2 항체 약물 접합체 및 이의 용도 |
| TW202506729A (zh) * | 2023-04-11 | 2025-02-16 | 美商麥迪紐有限責任公司 | Ｓｔｅａｐ２定向ｔ細胞接合物及其組成物 |
| WO2024215948A1 (en) * | 2023-04-12 | 2024-10-17 | Fusion Pharmaceuticals Inc. | Steap2–targeted compounds and use thereof |
| WO2025068803A1 (en) * | 2023-09-26 | 2025-04-03 | Astrazeneca Ab | Therapeutic combinations comprising anti-steap2 chimeric antigen receptor t cells |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005079490A2 (en) * | 2004-02-13 | 2005-09-01 | Nuvelo, Inc. | Methods of therapy and diagnosis using targeting of cells that express steap2 polypeptides |
| AU2010291902A1 (en) * | 2009-09-14 | 2012-04-05 | Dyax Corp. | Libraries of genetic packages comprising novel HC CDR3 designs |
| CA2780221A1 (en) * | 2009-11-04 | 2011-05-12 | Fabrus Llc | Methods for affinity maturation-based antibody optimization |
| MY199468A (en) * | 2016-09-23 | 2023-10-31 | Regeneron Pharma | Anti-steap2 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind steap2 and cd3, and uses thereof |
| IL311860A (en) * | 2018-08-02 | 2024-06-01 | Kite Pharma Inc | Treatment with receptor-antigen chimeric kinetics of T cell expansion and their uses |
| US20210213119A1 (en) * | 2018-08-28 | 2021-07-15 | Immunotech Biopharm Co., Ltd. | Improved therapeutic t cell |
| IL318344A (en) * | 2022-07-15 | 2025-03-01 | Medimmune Llc | Methods for expanding T cell populations |
-
2022
- 2022-10-14 CA CA3234494A patent/CA3234494A1/en active Pending
- 2022-10-14 WO PCT/IB2022/059885 patent/WO2023062604A1/en not_active Ceased
- 2022-10-14 EP EP22880526.3A patent/EP4415727A4/en active Pending
- 2022-10-14 IL IL312003A patent/IL312003A/en unknown
- 2022-10-14 CN CN202280069215.1A patent/CN118103050A/zh active Pending
- 2022-10-14 MX MX2024004620A patent/MX2024004620A/es unknown
- 2022-10-14 US US18/046,728 patent/US20230192803A1/en active Pending
- 2022-10-14 JP JP2024522219A patent/JP2024539630A/ja active Pending
- 2022-10-14 AU AU2022362872A patent/AU2022362872A1/en active Pending
- 2022-10-14 TW TW111139110A patent/TW202342507A/zh unknown
- 2022-10-14 KR KR1020247015923A patent/KR20240099281A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7575100B2 (ja) | 免疫細胞活性化のための二重特異性抗体 | |
| JP7809680B2 (ja) | 癌処置のための多重特異性結合タンパク質 | |
| JP2024539630A5 (https=) | ||
| US20220411536A1 (en) | Multispecific antibody | |
| WO2022105832A1 (zh) | 抗pd-l1纳米抗体及三功能融合蛋白 | |
| CN116457372A (zh) | 联合治疗 | |
| AU2021302126B2 (en) | Binding protein having h2l2 and hcab structures | |
| CN116199785A (zh) | 多特异性抗体及其制备和使用方法 | |
| CN113150156B (zh) | 抗tigit抗体及其用途 | |
| JP2022512891A5 (https=) | ||
| CA3207791A1 (en) | Anti-cd112r antibody and use thereof | |
| TW202221041A (zh) | 一種結合人pd-l1的抗體 | |
| AU2022317822A1 (en) | Novel anti-sirpa antibodies | |
| CN110964114A (zh) | 一种双靶点抗原结合分子 | |
| HK40082471A (en) | Binding protein having h2l2 and hcab structures | |
| KR20260032990A (ko) | Her2 키메라 항원 수용체 분비 | |
| HK40116729A (zh) | 包含TGF-βRII胞外区片段的融合蛋白、其药物组合物及用途 | |
| HK40088418A (zh) | 多特异性抗体及其制备和使用方法 | |
| HK40088417A (zh) | 多特异性抗体及其制备和使用方法 | |
| CN118126178A (zh) | 抗pd-1-ctla-4双特异性抗体及其用途 | |
| KR20220092432A (ko) | 뮤신 1에 특이적인 폴리펩티드 및 이의 이용 | |
| HK40018991A (en) | Multi-specific antibodies and methods of making and using thereof |